Cargando…
Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator
The parathyroid hormone type 1 receptor (PTH1R) acts as a canonical class B G protein-coupled receptor, regulating crucial functions including calcium homeostasis and bone formation. The identification and development of PTH1R non-peptide allosteric modulators have obtained widespread attention. It...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818451/ https://www.ncbi.nlm.nih.gov/pubmed/36611834 http://dx.doi.org/10.3390/cells12010041 |
_version_ | 1784864989165649920 |
---|---|
author | Li, Mengrong Bao, Yiqiong Xu, Ran Li, Miaomiao Xi, Lili Guo, Jingjing |
author_facet | Li, Mengrong Bao, Yiqiong Xu, Ran Li, Miaomiao Xi, Lili Guo, Jingjing |
author_sort | Li, Mengrong |
collection | PubMed |
description | The parathyroid hormone type 1 receptor (PTH1R) acts as a canonical class B G protein-coupled receptor, regulating crucial functions including calcium homeostasis and bone formation. The identification and development of PTH1R non-peptide allosteric modulators have obtained widespread attention. It has been found that a negative allosteric modulator (NAM) could inhibit the activation of PTH1R, but the implied mechanism remains unclear. Herein, extensive molecular dynamics simulations together with multiple analytical approaches are utilized to unravel the mechanism of PTH1R allosteric inhibition. The results suggest that the binding of NAM destabilizes the structure of the PTH1R–PTH–spep/qpep (the C terminus of Gs/Gq proteins) complexes. Moreover, the presence of NAM weakens the binding of PTH/peps (spep and qpep) and PTH1R. The intra- and inter-molecular couplings are also weakened in PTH1R upon NAM binding. Interestingly, compared with our previous study of the positive allosteric effects induced by extracellular Ca(2+), the enhanced correlation between the PTH and G-protein binding sites is significantly reduced by the replacement of this negative allosteric regulator. Our findings might contribute to the development of new therapeutic agents for diseases caused by the abnormal activation of PTH1R. |
format | Online Article Text |
id | pubmed-9818451 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98184512023-01-07 Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator Li, Mengrong Bao, Yiqiong Xu, Ran Li, Miaomiao Xi, Lili Guo, Jingjing Cells Article The parathyroid hormone type 1 receptor (PTH1R) acts as a canonical class B G protein-coupled receptor, regulating crucial functions including calcium homeostasis and bone formation. The identification and development of PTH1R non-peptide allosteric modulators have obtained widespread attention. It has been found that a negative allosteric modulator (NAM) could inhibit the activation of PTH1R, but the implied mechanism remains unclear. Herein, extensive molecular dynamics simulations together with multiple analytical approaches are utilized to unravel the mechanism of PTH1R allosteric inhibition. The results suggest that the binding of NAM destabilizes the structure of the PTH1R–PTH–spep/qpep (the C terminus of Gs/Gq proteins) complexes. Moreover, the presence of NAM weakens the binding of PTH/peps (spep and qpep) and PTH1R. The intra- and inter-molecular couplings are also weakened in PTH1R upon NAM binding. Interestingly, compared with our previous study of the positive allosteric effects induced by extracellular Ca(2+), the enhanced correlation between the PTH and G-protein binding sites is significantly reduced by the replacement of this negative allosteric regulator. Our findings might contribute to the development of new therapeutic agents for diseases caused by the abnormal activation of PTH1R. MDPI 2022-12-22 /pmc/articles/PMC9818451/ /pubmed/36611834 http://dx.doi.org/10.3390/cells12010041 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Mengrong Bao, Yiqiong Xu, Ran Li, Miaomiao Xi, Lili Guo, Jingjing Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator |
title | Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator |
title_full | Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator |
title_fullStr | Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator |
title_full_unstemmed | Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator |
title_short | Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator |
title_sort | understanding the allosteric modulation of pth1r by a negative allosteric modulator |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818451/ https://www.ncbi.nlm.nih.gov/pubmed/36611834 http://dx.doi.org/10.3390/cells12010041 |
work_keys_str_mv | AT limengrong understandingtheallostericmodulationofpth1rbyanegativeallostericmodulator AT baoyiqiong understandingtheallostericmodulationofpth1rbyanegativeallostericmodulator AT xuran understandingtheallostericmodulationofpth1rbyanegativeallostericmodulator AT limiaomiao understandingtheallostericmodulationofpth1rbyanegativeallostericmodulator AT xilili understandingtheallostericmodulationofpth1rbyanegativeallostericmodulator AT guojingjing understandingtheallostericmodulationofpth1rbyanegativeallostericmodulator |